News & Announcements

Jim Donovan

A strong supporter of medical research, particularly within cancer, Jim Donovan of Goldman Sachs was nominated on March 14th.


The FNIH Biomarkers Consortium is launching a three-year research partnership to develop new methods for analyzing digital images, which will lead to new ways to track a patient’s response to cancer therapy.

Driven to Cure

New donation to the FNIH will support the research of W. Marston Linehan, M.D., at the National Cancer Institute, who is developing novel approaches to treat multiple forms of kidney cancer.


Dr. Maria Freire Appears on PBS’ The Open Mind with Alexander Heffner

The FNIH President and Executive Director, Dr. Maria Freire, speaks about the transformative nature of biomedical research.

Eliminate Dengue Program

The Eliminate Dengue program is ramping up after discovering that the presence of Wolbachia bacteria in Aedes aegypti mosquitoes inhibits replication of the Zika virus.

How Biopharmaceutical Collaborations Are Fueling Biomedical Innovation

David Wholley, FNIH Director of Research Partnerships, is featured in this Deloitte Consulting LLP report, contracted by PhRMA, about how collaborations have become essential in driving innovation in patient treatment and care.

Front Page: